Summary Curida AS (Curida) is a contract development and manufacturing organization that manufactures sterile liquid pharmaceuticals based on unit-dose Blow-Fill-Seal (BFS) technology.It specializes in the development of nasal and inhalation drug products.
The company provides laboratory, analytical, chemical testing, stability studies and microbiological services among others.Curida’s method development and validation services include identification, assay testing, testing for impurities, stability indication methods and microbiological method development.
The company caters its products and services to start-ups and early stage biotechnology and pharmaceutical companies.It operates through its manufacturing facility located in Elverum, Norway.
Curida is headquartered in Oslo, Norway.
Curida AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
274 pages •
By Asia Market Information & Development Company
• Jun 2020
China’s demand for Blood Products has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
134 pages •
By Global Industry Analysts
• Jul 2020
Global Pharmaceutical Contract Packaging Market to Reach US$17.1 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Pharmaceutical Contract Packaging estimated at US$11.3 Billion in the year 2020, is projected to reach a revised size of US$17.1 Billion by 2027, growing at a CAGR of 6.1% over the analysis period...
Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H1 2020 Summary Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) pipeline Target constitutes close to 46 molecules. Out of which approximately...
Metabotropic Glutamate Receptor 4 - Pipeline Review, H1 2020 Summary According to the recently published report ’Metabotropic Glutamate Receptor 4 – Pipeline Review, H1 2020’; Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to 8 molecules. Out of which...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this US Pharmacy Benefit Management Market Report The pharmacy benefit management market in US is expected to grow at a CAGR of over 7% during the period 2019–2025. The U.S. healthcare landscape is complex. It is riddled with wastage, drug abuse,...
Global Genetic Disorders Partnering 2014 to 2020 provides the full collection of Genetic Disorders disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Genetic Disorders partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genetic...
Online Pharmacy Market Research Report by Type (Non-prescription and Prescription), by Distribution Channel (App only and Online store) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Online Pharmacy Market is expected to grow from USD 35,239.48 Million in 2019 to USD 72,226.68 Million by the end...
Pharmaceutical Contract Manufacturing Market Research Report by Type of Contract Manufacturing (API or Bulk Drug Manufacturing and Final Dosage Form) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Pharmaceutical Contract Manufacturing Market is expected to grow from USD 87,209.52 Million in 2019...
Tularaemia - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia – Pipeline Review, H1 2020, provides an overview of the Tularaemia (Infectious Disease) pipeline landscape. Tularaemia is an infection caused due to a bacterium called...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.